In clinical trials, investigations focus upon whether a treatment affects a measured outcome. Data often collected include pre- and post-treatment measurements on each patient and an analysis of the change in the outcome is typically performed to determine treatment efficacy. Absolute change and relative change are frequently selected as the outcome. In selecting from these two measures, the analyst makes implicit assumptions regarding the mean and variance-mean relationship of the data. Some have provided ad hoc guidelines for selecting between the two measures. We present a more rigorous means of investigating change using quasi-likelihoods. We show that both absolute change and relative change are special cases of the specified quasi-likelihood model. A cystic fibrosis example is provided.
Analysing change in clinical trials using quasi-likelihoods
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.